Bamco Inc. NY Sells 39,378 Shares of Illumina, Inc. $ILMN

Illumina stock performance and analyst ratings changes

Mar. 16, 2026 at 8:19am

Got story updates? Submit your updates here. ›

Bamco Inc. NY reduced its holdings in shares of Illumina, Inc. (NASDAQ:ILMN) by 15.9% in the third quarter, according to the company's 13F filing with the Securities and Exchange Commission. The firm owned 208,094 shares of the life sciences company's stock after selling 39,378 shares during the period.

Why it matters

This transaction by Bamco Inc. NY provides insight into institutional investor activity and sentiment around Illumina, a leading life sciences company. The stock's performance and analyst ratings changes are also relevant for investors tracking the company.

The details

Bamco Inc. NY sold 39,378 shares of Illumina, reducing its stake by 15.9% in the third quarter. The firm now owns 208,094 shares, or 0.14% of Illumina. Several other hedge funds have also recently made changes to their Illumina holdings, with some increasing and others decreasing their positions. Illumina's stock has seen a range of $68.70 to $155.53 over the past 52 weeks, and currently trades around $118.94 with a market cap of $18.19 billion.

  • Bamco Inc. NY reduced its Illumina holdings in the third quarter of the year.
  • Illumina's stock has ranged from a 52-week low of $68.70 to a high of $155.53.

The players

Bamco Inc. NY

An investment management firm that reduced its stake in Illumina by 15.9% in the third quarter.

Illumina, Inc.

A global life sciences company that develops and markets integrated systems for genetic analysis.

Got photos? Submit your photos here. ›

The takeaway

This transaction by Bamco Inc. NY highlights the shifting institutional investor sentiment around Illumina, a key player in the life sciences industry. The stock's performance and analyst ratings will continue to be closely watched by investors.